MARILYN BATAILLE: Open Payments
NPI 1538596929 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,364 in 76 payments from 20 companies in 2025. Trend: 2023 $1,520 · 2024 $1,127 · 2025 $1,364
Food & beverage: $1,364
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 20 | $207 |
| GlaxoSmithKline, LLC. | 10 | $203 |
| Sumitomo Pharma America, Inc. | 7 | $174 |
| Novo Nordisk Inc | 6 | $110 |
| PFIZER INC. | 5 | $104 |
| Merck Sharp & Dohme LLC | 3 | $69 |
| Lilly USA, LLC | 3 | $66 |
| Astellas Pharma US Inc | 3 | $61 |
| ABBVIE INC. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
Products named: GEMTESA, TRELEGY ELLIPTA, OTEZLA, EVENITY, Rybelsus, GARDASIL 9, Veozah, CAPLYTA.
Industry payments across FL — which companies pay providers there.
